Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 09-sep-2026 · last seen 09-sep-2026

Ammonia-Lowering Agents

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-08-01 — Ammonia Metabolism in the Aging Liver: Emerging Mechanistic Insights.: Narrative review reframes age-related decline of hepatic urea-cycle and glutamine-synthesis capacity as converting ammonia into a bioactive stress signal driving mitochondrial injury, senescence, proteostasis failure, and liver–brain/liver–muscle/liver–gut deterioration, positioning ammonia-lowering agents (e.g. lactulose, rifaximin, LOLA, sodium phenylbutyrate/benzoate) as candidate healthspan interventions rather than only overt hepatic encephalopathy drugs — conceptual synthesis, no new outcome data. [mechanism-plausible] (novelty: 3)

Open questions

Related

Contributing findings

pubmed review mechanism-plausible
Ammonia Metabolism in the Aging Liver: Emerging Mechanistic Insights.
01-aug-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18